SAR-125844 Uses, Dosage, Side Effects and more

SAR-125844 is under investigation in clinical trial NCT01391533 (Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors).

Attribute	Details
Trade Name	SAR-125844
Generic	SAR-125844
Type
Formula	C25H23FN8O2S2
Weight	Average: 550.63 Monoisotopic: 550.136942524
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	January 7, 2025 at 1:49 am

Innovators Monograph